Takaji Miyake

1.2k citations
7 papers · 949 indexed · 1 hit paper · h-index 5

Takaji Miyake

7 papers receiving 874 citations

Hit Papers

Isolation and characterization of genomic and cDNA clones...8291985202619982012250500750

Peers

Takaji Miyake
Comparison fields: 5 of 82
  • Hematology 684
  • Biochemistry 97
  • Genetics 145
  • Nephrology 73
  • Physiology 232
Replace Abbey Willcox with:
Abbey Willcox Australia
Marion Lebois Australia
Marlyse A. Debrincat Australia
K Hirashima Japan
Ping Qin China
Haley E. Ramsey United States
M Zushi Japan
Mark S. Brower United States
Harlan N. Bradford United States
R. Serafini Italy
Takaji Miyake relative to Abbey Willcox Australia Abbey Willcox's profile →
Citations per field
00.5×4.3×
Abbey Willcox · 1×
Citations per year

Countries citing papers authored by Takaji Miyake

Since Specialization
Citations

This map shows the geographic impact of Takaji Miyake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takaji Miyake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takaji Miyake more than expected).

Fields of papers citing papers by Takaji Miyake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takaji Miyake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takaji Miyake. The network helps show where Takaji Miyake may publish in the future.

Co-authorship network

The 21 scholars most cited alongside Takaji Miyake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takaji Miyake Line = papers co-authored together Takaji Miyake links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 198759
2 19862
3 19863
4
Isolation and characterization of genomic and cDNA clones of human erythropoietinbreakdown →
1985829
5 198214
6 198119
7 198023

About Takaji Miyake

Takaji Miyake is a scholar working on Hematology, Internal Medicine, Biochemistry, Microbiology and Pathology and Forensic Medicine, having authored 7 papers that have together received 949 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (3 papers), Platelet Disorders and Treatments (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Glycosylation and Glycoproteins Research (1 paper), Blood properties and coagulation (1 paper), Virus-based gene therapy research (1 paper), Pluripotent Stem Cells Research (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Hematology (684 citations), Biochemistry (97 citations), Genetics (145 citations), Nephrology (73 citations) and Physiology (232 citations). Takaji Miyake has collaborated with scholars based in United States and Japan. Frequent co-authors include Makoto Kawakita, Tomoe Shimizu, Rodney M. Hewick, S D Neill, Charles B. Shoemaker, Edward F. Fritsch, Randal J. Kaufman, Kenneth Jacobs, Richard Rudersdorf and Simon S. Jones. Their work appears in journals such as British Journal of Haematology, Pathobiology, Nature and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026